Effect of therapeutic integrin (CD11a) blockade with efalizumab on immune responses to model antigens in humans: results of a randomized, single blind study. [electronic resource]
Producer: 20081030Description: 2615-2624 p. digitalISSN:- 1523-1747
- Adult
- Aged
- Antibodies, Bacterial -- metabolism
- Antibodies, Monoclonal -- immunology
- Antibodies, Monoclonal, Humanized
- Antibody Formation -- drug effects
- Antigens, Bacterial -- pharmacology
- B-Lymphocytes -- drug effects
- Bacteriophage phi X 174 -- immunology
- CD11a Antigen -- drug effects
- Female
- Humans
- Immunoglobulin G -- metabolism
- Immunoglobulin M -- metabolism
- Male
- Middle Aged
- Pneumococcal Vaccines -- pharmacology
- Psoriasis -- drug therapy
- Single-Blind Method
- Skin Tests
- T-Lymphocytes -- drug effects
- Tetanus Toxoid -- pharmacology
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.